We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current XTLB market cap is 7.85M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -225k | -251k | -163k | -151k | -200k |
| Net Income | -748k | -919k | -364k | -215k | -284k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -842k | -948k | -1.03M | -880k | -765k |
| Net Income | -1.35M | -782k | 435k | -1.35M | -1.78M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.19M | 3.32M | 2.88M | 2.66M | 2.43M |
| Total Liabilities | 187k | 241k | 163k | 162k | 206k |
| Total Equity | 4M | 3.08M | 2.72M | 2.5M | 2.22M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.21M | 6.5M | 6.62M | 4.19M | 2.43M |
| Total Liabilities | 232k | 254k | 1.29M | 187k | 206k |
| Total Equity | 6.98M | 6.25M | 5.33M | 4M | 2.22M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -901k | N/A | N/A | N/A | -707k |
| Investing | 36k | N/A | N/A | N/A | 41k |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -908k | -850k | 2.87M | -901k | -707k |
| Investing | 2.11M | 32k | 8k | 36k | 41k |
| Financing | N/A | N/A | 385k | N/A | N/A |
| Market Cap | 7.85M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 5.45M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 1.85 (71.15%) |
| Company Name | XTL Biopharmaceuticals Ltd |
| Address |
5 badner st ramat gan, center 5218102 |
| Website | https://www.xtlbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
